Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Fosfomycin Disodium
2. 26016-99-9
3. Phosphonemycin
4. Fosfomycin Disodium Salt
5. Phosphomycin Disodium Salt
6. Veramina
7. Disodium Phosphonomycin
8. Disodium (1r,2s)-(1,2-epoxypropyl)phosphonate
9. Fosfomycin Sodium [jan]
10. Disodium Fosfomycin
11. Priomicina
12. Fosfomycin Sodium Salt
13. 97mmo19fno
14. Fosfocina Disodium Salt
15. Phosphonomycin Disodium Salt
16. Sodium Fosfomycin
17. Phosphonomycin Sodium
18. Phosphonic Acid, [(2r,3s)-3-methyloxiranyl]-, Disodium Salt
19. Disodium [(2r,3s)-3-methyloxiran-2-yl]phosphonate
20. Fom-na
21. Mk 955
22. Fosfocin
23. Forocyle S
24. Fosmicin S
25. Nsc-136017
26. Einecs 247-409-2
27. Unii-97mmo19fno
28. Nsc 136017
29. Levo-phosphonomycin Disodium Salt
30. (?)-fosfomycin
31. Fosmicin S (tn)
32. Phosphonemycin Disodium
33. (2r-cis)-(3-methyloxiranyl)phosphonic Acid Disodium Salt
34. (1r,2s)(-)-(1,2-epoxypropyl)phosphonic Acid Disodium Salt
35. Phosphonic Acid, (3-methyloxiranyl)-, Disodium Salt, (2r-cis)-
36. Fosfomycin Sodium (jp17)
37. Schembl9634056
38. Chembl1256140
39. Fosfomycin Sodium [mart.]
40. Dtxsid401017220
41. Fosfomycin Sodium [who-dd]
42. Mfcd00056853
43. Phosphonic Acid, (1,2-epoxypropyl)-, Disodium Salt (1r,2s) (-)-
44. Akos015963278
45. Ccg-266439
46. Fosfomycin Sodium [ep Impurity]
47. Fosfomycin Sodium [ep Monograph]
48. 25162-71-4
49. As-11021
50. As-13713
51. F0889
52. Disodium (1r,2s)-1,2-epoxypropylphosphonate
53. D02188
54. Sodium ((2r,3s)-3-methyloxiran-2-yl)phosphonate
55. Fosfomycin Sodium, Vetranal(tm), Analytical Standard
56. Q27272022
57. (1r,2s)-1,2-epoxypropylphosphonic Acid Disodium Salt
58. Disodium (2r,3s)-3-methyloxiran-2-ylphosphonate
59. Phosphomycin Disodium Salt, Antibacterial Mura Inhibitor
60. Z1583387379
61. Phosphonic Acid,(3-methyloxiranyl)-,disodium Salt,cis-(+-)-
62. Disodium;[(2r,3s)-3-methyloxiran-2-yl]-dioxido-oxo-lambda5-phosphane
Molecular Weight | 182.02 g/mol |
---|---|
Molecular Formula | C3H5Na2O4P |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 181.97208420 g/mol |
Monoisotopic Mass | 181.97208420 g/mol |
Topological Polar Surface Area | 75.7 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 127 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ABOUT THIS PAGE
32
PharmaCompass offers a list of Fosfomycin Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fosfomycin Sodium manufacturer or Fosfomycin Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fosfomycin Sodium manufacturer or Fosfomycin Sodium supplier.
PharmaCompass also assists you with knowing the Fosfomycin Sodium API Price utilized in the formulation of products. Fosfomycin Sodium API Price is not always fixed or binding as the Fosfomycin Sodium Price is obtained through a variety of data sources. The Fosfomycin Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fosfomycin disodium salt manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fosfomycin disodium salt, including repackagers and relabelers. The FDA regulates Fosfomycin disodium salt manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fosfomycin disodium salt API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fosfomycin disodium salt manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fosfomycin disodium salt supplier is an individual or a company that provides Fosfomycin disodium salt active pharmaceutical ingredient (API) or Fosfomycin disodium salt finished formulations upon request. The Fosfomycin disodium salt suppliers may include Fosfomycin disodium salt API manufacturers, exporters, distributors and traders.
click here to find a list of Fosfomycin disodium salt suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fosfomycin disodium salt DMF (Drug Master File) is a document detailing the whole manufacturing process of Fosfomycin disodium salt active pharmaceutical ingredient (API) in detail. Different forms of Fosfomycin disodium salt DMFs exist exist since differing nations have different regulations, such as Fosfomycin disodium salt USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Fosfomycin disodium salt DMF submitted to regulatory agencies in the US is known as a USDMF. Fosfomycin disodium salt USDMF includes data on Fosfomycin disodium salt's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Fosfomycin disodium salt USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Fosfomycin disodium salt suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fosfomycin disodium salt Drug Master File in Japan (Fosfomycin disodium salt JDMF) empowers Fosfomycin disodium salt API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fosfomycin disodium salt JDMF during the approval evaluation for pharmaceutical products. At the time of Fosfomycin disodium salt JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fosfomycin disodium salt suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fosfomycin disodium salt as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fosfomycin disodium salt API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fosfomycin disodium salt as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fosfomycin disodium salt and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fosfomycin disodium salt NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fosfomycin disodium salt suppliers with NDC on PharmaCompass.
Fosfomycin disodium salt Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fosfomycin disodium salt GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fosfomycin disodium salt GMP manufacturer or Fosfomycin disodium salt GMP API supplier for your needs.
A Fosfomycin disodium salt CoA (Certificate of Analysis) is a formal document that attests to Fosfomycin disodium salt's compliance with Fosfomycin disodium salt specifications and serves as a tool for batch-level quality control.
Fosfomycin disodium salt CoA mostly includes findings from lab analyses of a specific batch. For each Fosfomycin disodium salt CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fosfomycin disodium salt may be tested according to a variety of international standards, such as European Pharmacopoeia (Fosfomycin disodium salt EP), Fosfomycin disodium salt JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fosfomycin disodium salt USP).